• Loading stock data...
Est. 2004

Monday 03/25/2019

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More


  • 12:19 PM

    Reported by OTC Markets. We are pleased to share current information and developments with our stakeholders and the public, February 19, 2019. Regarding Lifelines investment in Cyrcadia, Inc. (CI), CIs largest shareholder at approximately 35%, Cyrcadia has reported the resumption of its clinical studies at El Camino Hospital (ECH) in Mountain View, CA. The resumption of the studies is the result of improvements to both the iTBra system (hardware and application interface) and improvement of the underlying predictive analytics. The

    Read more
  • 12:48 PM

    Doral, Nov. 07, 2017, ETST, (GLOBE NEWSWIRE) —  Earth Science Tech, Inc. (OTC PINK: ETST) (“ETST” or “the Company”), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical, medical device, research and development, initiates audit process through BF Borgers CPA PC to up-list to the OTCQB Market. ETST’s key factor to up-listing to the OTCQB is to expand its shareholder base and comply to engaged institution funders. BF Borgers has commenced the audit process

    Read more
  • 12:23 PM

    Apr 11, 2017, ETST OTC Disclosure & News Service – Hollywood, April 11, 2017 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC:ETST OTCBB:ETST $ETST OTC PINK:ETST) (“ETST” or “the Company”), an innovative biotech company focused on cannabis (industrial hemp) and cannabinoid research and development, nutraceuticals, pharmaceuticals, and medical devices, and its two subsidiaries Earth Science Pharmaceutical Inc. and Cannabis Therapeutics Inc., are proud to announce that they will be targeting breast cancer and other women’s health issues with their latest

    Read more
  • 3:22 PM

    REDONDO BEACH, CA–(Marketwired – Nov 21, 2016) – SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces an article covering Pressure BioSciences Inc.’s (OTCQB: PBIO) recently announced financial results, how these record results were achieved, and where the company is headed in the near future. Pressure BioSciences recorded record product and service revenue that increased 4% to $500,949 during the third quarter driven by a 13% increase in instrument sales. At the

    Read more
  • 5:45 PM

    KEEGO HARBOR, MI–ZIVO, (Marketwired – Nov 2, 2016) – ZIVO Bioscience, Inc. (OTCQB: ZIVO) announces today that from July 1, 2016 to date, the Company has received $2 million in new capital funding as part of its Q3/Q4 capital funding initiative. This brings the total of new funding to $3.25 million year to date. In related news, the ZIVO Board of Directors recently approved an increase in the available credit line from HEP Investments, LLC to $17.5 million. To accommodate

    Read more
Public Wire Banner